These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6205446)

  • 1. Principia of cancer therapy. III. Perpetuation principle of repairable chemotherapeutic damage: cisplatin-bleomycin in vitro.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):5-7. PubMed ID: 6205446
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethanol-induced cell sensitization to bleomycin cytotoxicity and the inhibition of recovery from potentially lethal damage.
    Mizuno S
    Cancer Res; 1981 Oct; 41(10):4111-4. PubMed ID: 6169432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants.
    Liu B; Cvijic ME; Jetzt A; Chin KV
    Cell Growth Differ; 1996 Aug; 7(8):1105-12. PubMed ID: 8853907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effects of 60Co gamma-rays and continuous low concentrations of bleomycin on cultured mammalian cells.
    Kobayashi H; Sakuma S
    Nagoya J Med Sci; 1984 Mar; 46(1-4):27-33. PubMed ID: 6204204
    [No Abstract]   [Full Text] [Related]  

  • 5. Consecutive, multimodal therapy of cancer: selective biological initiation (OK-432), cytoplasmic and nuclear damage (FT-207 and cyclophosphamide), inhibition of repair (bleomycin), and activation of cleansing and surveillance mechanisms.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1981 Dec; 28(1-4):7-14. PubMed ID: 6179159
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells.
    Laurencot CM; Kennedy KA
    Oncol Res; 1995; 7(7-8):371-9. PubMed ID: 8747600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringin, a grapefruit flavanone, protects V79 cells against the bleomycin-induced genotoxicity and decline in survival.
    Jagetia A; Jagetia GC; Jha S
    J Appl Toxicol; 2007; 27(2):122-32. PubMed ID: 17177233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.
    Miller RA; Woodburn KW; Fan Q; Lee I; Miles D; Duran G; Sikic B; Magda D
    Clin Cancer Res; 2001 Oct; 7(10):3215-21. PubMed ID: 11595717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of cycling and noncycling cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and to bleomycin.
    Hahn GM; Gordon LF; Kurkjian SD
    Cancer Res; 1974 Sep; 34(9):2373-7. PubMed ID: 4135685
    [No Abstract]   [Full Text] [Related]  

  • 11. The in vitro study of influence of antioxidant enzymes level and repair capacity on cytotoxic bleomycin activity in human and mouse cells.
    Gruber BM; Anuszewska EL
    Acta Pol Pharm; 2000; 57(2):105-11. PubMed ID: 10934788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of x-ray and bleomycin in cancer cell survival.
    Matsuzawa T; Okuyama S; Awano T; Takazawa K
    Panminerva Med; 1976; 18(3-4):103-4. PubMed ID: 56736
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of hyperthermia and chemotherapy in animals.
    Marmor JB
    Cancer Res; 1979 Jun; 39(6 Pt 2):2269-76. PubMed ID: 87264
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction between bleomycin and glutathione in cancer-bearing animals.
    Kaneda T; Ichikawa H
    Nagoya J Med Sci; 1978 Mar; 40(3-4):81-91. PubMed ID: 78448
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative chemosensitivity of exponential- versus plateau-phase cells in both in vitro model systems.
    Twentyman PR
    Cancer Treat Rep; 1976 Dec; 60(12):1719-22. PubMed ID: 67890
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
    Tikoo K; Ali IY; Gupta J; Gupta C
    Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of X-rays and bleomycin on cultured mammalian cells].
    Masuda K; Takaki T; Wakisaka S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Jul; 42(7):691-700. PubMed ID: 6183637
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of experimental data for the improvement of the therapeutical effect of bleomycin.
    Caputo A
    Prog Biochem Pharmacol; 1976; 11():2-17. PubMed ID: 63965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):31-4. PubMed ID: 3870142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.